Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids

Br J Haematol. 2012 Apr;157(2):249-52. doi: 10.1111/j.1365-2141.2011.08937.x. Epub 2011 Nov 15.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Anemia, Sickle Cell* / blood
  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / administration & dosage*
  • Female
  • Humans
  • Hydroxyurea / administration & dosage*
  • Infant
  • Male
  • Nucleic Acids / blood*
  • alpha-Thalassemia* / blood
  • alpha-Thalassemia* / complications
  • alpha-Thalassemia* / drug therapy

Substances

  • Antisickling Agents
  • Nucleic Acids
  • Hydroxyurea